Log in to save to my catalogue

Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2...

Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8307543

Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection

About this item

Full title

Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2021-07, Vol.118 (29), p.1-8

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection continues to be a serious global public health threat. The 3C-like protease (3CLpro) is a virus protease encoded by SARS-CoV-2, which is essential for virus replication. We have previously reported a series of small-molecule 3CLpro inhibitors effective for inhibiting replication...

Alternative Titles

Full title

Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8307543

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8307543

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.2101555118

How to access this item